These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 15648057)
1. [18F]FDOPA PET and clinical features in parkinsonism due to manganism. Racette BA; Antenor JA; McGee-Minnich L; Moerlein SM; Videen TO; Kotagal V; Perlmutter JS Mov Disord; 2005 Apr; 20(4):492-496. PubMed ID: 15648057 [TBL] [Abstract][Full Text] [Related]
2. [Diagnostic utility of positron emission tomography for parkinsonism after chronic manganese exposure]. Abe Y; Kachi T; Kato T; Ito K; Yanagisawa N; Sobue G Rinsho Shinkeigaku; 1999 Jul; 39(7):693-9. PubMed ID: 10548904 [TBL] [Abstract][Full Text] [Related]
3. Manganese-induced parkinsonism and Parkinson's disease. Olanow CW Ann N Y Acad Sci; 2004 Mar; 1012():209-23. PubMed ID: 15105268 [TBL] [Abstract][Full Text] [Related]
4. Idiopathic parkinsonism with superimposed manganese exposure: utility of positron emission tomography. Kim Y; Kim JW; Ito K; Lim HS; Cheong HK; Kim JY; Shin YC; Kim KS; Moon Y Neurotoxicology; 1999; 20(2-3):249-52. PubMed ID: 10385888 [TBL] [Abstract][Full Text] [Related]
8. Secondary parkinsonism due to focal substantia nigra lesions: a PET study with [18F]FDG and [18F]fluorodopa. Boecker H; Weindl A; Leenders K; Antonini A; Kuwert T; Kruggel F; Grafin von Einsiedel H; Conrad B Acta Neurol Scand; 1996 Jun; 93(6):387-92. PubMed ID: 8836298 [TBL] [Abstract][Full Text] [Related]
15. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography. Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142 [TBL] [Abstract][Full Text] [Related]
16. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction. Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556 [TBL] [Abstract][Full Text] [Related]
17. [A case of familial juvenile dystonia-parkinsonism: 18F-6-fluorodopa and 18F-fluoro-2-deoxyglucose PET study]. Hanakawa T; Fukuyama H; Akiguchi I; Kato M; Kimura J; Shibasaki H Rinsho Shinkeigaku; 1996 May; 36(5):655-60. PubMed ID: 8905984 [TBL] [Abstract][Full Text] [Related]
18. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies. Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296 [TBL] [Abstract][Full Text] [Related]
19. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease. Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293 [TBL] [Abstract][Full Text] [Related]